ECG Everus Construction Group, Inc.
Operative Builders · NYSE · SEC CIK 2015845 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY33.5%
TTM net income YoY59.9%
TTM EPS YoY59.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin13.6%
Operating margin8.2%
Net margin6.2%
FCF margin5.1%
EBITDA margin8.9%
Returns
ROE40.3%
ROA13.4%
ROIC (approx.)30.0%
Asset turnover2.15x
Leverage & solvency
Liabilities / assets68.1%
Debt / equity0.66x
Current ratio1.53x
Interest coverage18.67x
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio-1.2%
Payout ratio—
Capex / revenue1.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $3.75B | $2.85B |
| Cost of revenue | $3.29B | $2.51B |
| Gross profit | $454.09M | $339.45M |
| SG&A expense | $189.34M | $149.54M |
| Operating income | $264.75M | $189.91M |
| Interest expense | $21.45M | $14.02M |
| Pretax income | $257.81M | $180.76M |
| Income tax | $72.31M | $49.52M |
| Net income | $201.77M | $143.42M |
| EBITDA | $293.43M | $213.29M |
| EPS (basic) | 3.95 | 2.81 |
| EPS (diluted) | 3.95 | 2.81 |
| Weighted avg. shares (diluted) | 51.12M | 51.07M |
| Balance sheet | ||
| Cash & equivalents | $170.50M | $86.01M |
| Receivables | $769.83M | $590.03M |
| Inventory | $45.27M | $43.75M |
| Current assets | $1.30B | $917.23M |
| PP&E, net | $168.50M | $134.41M |
| Goodwill | $143.22M | $143.22M |
| Intangibles | $0 | $116,000 |
| Total assets | $1.73B | $1.29B |
| Current liabilities | $736.19M | $513.37M |
| Short-term debt | $15.00M | $15.00M |
| Long-term debt | $266.55M | $280.65M |
| Total debt | $281.55M | $295.65M |
| Total liabilities | $1.10B | $865.85M |
| Shareholders' equity | $629.82M | $422.61M |
| Net debt | $111.05M | $209.64M |
| Shares outstanding | 51.01M | 50.98M |
| Cash flow statement | ||
| Operating cash flow | $156.84M | $163.38M |
| Capital expenditure | $66.84M | $48.28M |
| Free cash flow | $90.01M | $115.10M |
| Investing cash flow | -$56.77M | -$37.06M |
| Financing cash flow | -$15.59M | -$41.87M |
| Depreciation & amortization | $28.68M | $23.38M |
| Stock-based compensation | $6.31M | $1.56M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.